
Hiroto Inaba MD
Member, Leukemia/Lymphoma Division, Department of Oncology, St. Jude Children's Research Hospital Professor, Department of Pediatrics, University of Tennessee Health Science Center College of Medicine
Join to View Full Profile
St. Jude Children's Research Hospital262 Danny Thomas PlaceMemphis, TN 38105
Dr. Inaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2003 - 2006
- Children's Hospital of MichiganResidency, Pediatrics, 2000 - 2003
- OtherClass of 1991
Certifications & Licensure
- TN State Medical License 2003 - 2026
- MI State Medical License 2000 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies Start of enrollment: 2009 Sep 01
- NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma Start of enrollment: 2012 May 25
- Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Start of enrollment: 2017 Mar 29
- Join now to see all
Publications & Presentations
PubMed
- Reduced-Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B-Cell Acute Lymphoblastic Leukemia.Ashley C Holland, Jasmine Smith, Lu Wang, Bradley Muller, Hiroto Inaba
Pediatric Blood & Cancer. 2025-05-01 - Desensitization to calaspargase pegol appears to be less successful than pegaspargase.Milre Matherne, John C Panetta, Jaclyn Hopp, Hiroto Inaba, Ching-Hon Pui
Blood Advances. 2025-04-08 - 1 citationsDNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.Carolin S Escherich, Takaya Moriyama, Zhenhua Li, Yu-Chih Hsiao, Wenjian Yang
Blood. 2025-03-13
Journal Articles
- Association of Bacteremic Sepsis with Long-Term Neurocognitive Dysfunction in Pediatric Patients with Acute Lymphoblastic LeukemiaHiroto Inaba, Joshua Wolf, Kevin R Krull, Melissa M Hudson, JAMA
Press Mentions
- Clinical Trial Results Show Low-Intensity Therapy Can Achieve Positive Outcomes for Certain Pediatric Leukemia SubtypesSeptember 24th, 2024
- Celebrating Doctors’ Day: St. Jude Physicians Reflect on Their Career OriginsMarch 30th, 2021
- Clinical Characteristics and Outcomes of B-ALL with ZNF384 Rearrangements: A Retrospective Analysis by the Ponte Di Legno Childhood ALL Working GroupMarch 10th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: